BIOMAT Database Logo BIOMAT Database Logo

Initial and acquired drug resistance of Mycobacterium tuberculosis in east Delhi. 1996

M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
Department of Microbiology, University College of Medical Sciences, New Delhi.

One hundred and fifty six strains of Mycobacterium tuberculosis, isolated from cases of pulmonary tuberculosis were subjected to sensitivity test to detect initial and acquired drug resistance to Streptomycin, isoniazid, Rifampicin, Ethambutol and Pyrazinamide. Initial and acquired drug resistance was observed to one or more drugs in 16% and 24.4% of the patients respectively. Strains resistant to Rifampicin and Ethambutol were resistant to Isoniazid also. Drug resistance was unrelated to age and sex of the patients.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013183 Sputum Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus. Sputum, Induced,Induced Sputum,Induced Sputums,Sputums,Sputums, Induced

Related Publications

M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
Initial drug resistance of Mycobacterium tuberculosis in Taiwan.
November 1997, Journal of the Formosan Medical Association = Taiwan yi zhi,
M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
[Mycobacterium tuberculosis with initial drug resistance in silicotuberculosis and pulmonary tuberculosis patients].
March 1982, Problemy tuberkuleza,
M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India.
January 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
[Drug resistance in Mycobacterium tuberculosis: contribution of constituent and acquired mechanisms].
January 2018, Revista de salud publica (Bogota, Colombia),
M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
October 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
Association between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistance.
January 2013, PloS one,
M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
Drug resistance in Mycobacterium tuberculosis.
September 1995, The European respiratory journal. Supplement,
M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
Drug resistance in Mycobacterium tuberculosis.
July 2006, Current issues in molecular biology,
M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
June 2015, Emerging infectious diseases,
M Mahajan, and D S Agarwal, and D J Gadre, and N P Singh, and H C Gupta, and V Talwar
Drug resistance among Mycobacterium tuberculosis isolates from private clinics and a dots center in Delhi, India.
January 2011, The Southeast Asian journal of tropical medicine and public health,
Copied contents to your clipboard!